Neuromed Licenses Aureus Pharma's Ion Channel Database | GenomeWeb
NEW YORK (GenomeWeb News) - Neuromed has licensed an Aureus Pharma database for use in its drug-development programs, Aureus said today.
 
Under the agreement, Neuromed will use the company’s AurScope Ion Channel database to support development of its chronic pain drugs.
 
AurScope contains information from the scientific literature that can be used to study "all known" ion channels that apply to "all stages of the drug discovery process," Aureus said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.